Jain AB et al. |
Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721270
|
Abu-Elmagd KM et al. |
Four-hour versus 24-hour intravenous infusion of FK 506 in liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721271
|
Abu-Elmagd KM et al. |
Strategy of FK 506 therapy in liver transplant patients: effect of graft function. |
1991 |
Transplant. Proc. |
pmid:1721272
|
Ericzon BG et al. |
Pharmacokinetics of FK 506 during maintenance therapy in liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721273
|
DiLella AG and Craig RJ |
Characterization of the human FKBP-12 gene and related pseudogenes. |
1991 |
Transplant. Proc. |
pmid:1721302
|
Kar S and Carr B |
Gene expression of FK 506-binding protein. |
1991 |
Transplant. Proc. |
pmid:1721303
|
Connelly PR |
Thermodynamics of interaction of FK 506-binding protein and its ligands. |
1991 |
Transplant. Proc. |
pmid:1721304
|
Donnelly JG and Soldin SJ |
Purification of a 50- to 58-kDa immunophilin from human spleen and a Jurkat T-cell line capable of binding cyclosporine A, FK 506, and rapamycin. |
1991 |
Transplant. Proc. |
pmid:1721305
|
Winkler M et al. |
Use of FK 506 for treatment of chronic rejection after liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721334
|
D'Alessandro AM et al. |
FK 506 rescue therapy for resistant rejection episodes in liver transplant recipients. |
1991 |
Transplant. Proc. |
pmid:1721335
|
Lewis WD et al. |
FK 506 rescue therapy in liver transplant recipients with drug-resistant rejection. |
1991 |
Transplant. Proc. |
pmid:1721336
|
Woodle ES et al. |
FK 506: reversal of humorally mediated rejection following ABO-incompatible liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721337
|
Jordan ML et al. |
FK 506 conversion of renal allografts failing cyclosporine immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721365
|
Alessiani M et al. |
Infections in adult liver transplant patients under FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1703345
|
Offner G et al. |
FK 506 in a 14-year-old renal allograft recipient with cyclosporine-related liver nephrotoxicity: 1-year follow-up. |
1991 |
Transplant. Proc. |
pmid:1721366
|
Imai K et al. |
Histopathological study of canine pancreaticoduodenal allotransplantation with FK506, cyclosporine, and triple regimen immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1703347
|
|
Japanese study of FK 506 on kidney transplantation: the benefit of monitoring the whole blood FK 506 concentration. Japanese FK 506 Study Group. |
1991 |
Transplant. Proc. |
pmid:1721367
|
Starzl TE et al. |
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. |
1991 |
Transplant. Proc. |
pmid:1703351
|
Darras FS et al. |
Transplantation of pediatric en bloc kidneys under FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721368
|
Shapiro R et al. |
Kidney transplantation under FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1703352
|
Todo S et al. |
Clinical small bowel or small bowel plus liver transplantation under FK 506. |
1991 |
Transplant. Proc. |
pmid:1721369
|
Tzakis AG et al. |
Use of FK 506 in pediatric patients. |
1991 |
Transplant. Proc. |
pmid:1703353
|
DiMartini A et al. |
Psychiatric morbidity in liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721399
|
Lopez OL et al. |
Neuropathologic findings in liver transplantation: a comparative study of cyclosporine and FK 506. |
1991 |
Transplant. Proc. |
pmid:1721400
|
de Bruin RW et al. |
Fulminant graft-versus-host disease after FK 506 treatment in fully allogeneic small bowel transplantation. |
1991 |
Transplant. Proc. |
pmid:1721429
|
Langrehr JM et al. |
FK 506 inhibits nitric oxide production by cells infiltrating sponge matrix allografts. |
1991 |
Transplant. Proc. |
pmid:1721430
|
Gotoh M et al. |
Tolerance induction by liver grafting and FK 506 treatment in nonhuman primates. |
1991 |
Transplant. Proc. |
pmid:1721431
|
Valdivia LA et al. |
Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721432
|
Kay JE et al. |
Inhibition of T and B lymphocyte proliferation by rapamycin. |
1991 |
Immunology |
pmid:1709916
|
Ringe D |
Immunosuppression. Binding by design. |
1991 |
Nature |
pmid:1710317
|
Tropschug M and Hofmann R |
FK506 and protein kinase C. |
1991 |
Nature |
pmid:1710319
|
Albers MW et al. |
Relationship of FKBP to PKCI-2. |
1991 |
Nature |
pmid:1710782
|
Stevens C et al. |
The effects of immunosuppressive agents on in vitro production of human immunoglobulins. |
1991 |
Transplantation |
pmid:1710843
|
Metcalfe S and Milner J |
Evidence that FK506 and rapamycin block T cell activation at different sites relative to early reversible phosphorylation involving the protein phosphatases PP1 and PP2A. |
1991 |
Transplantation |
pmid:1710844
|
Deguchi K et al. |
Effects of FK 506 on acute experimental allergic encephalomyelitis. |
1991 |
Transplant. Proc. |
pmid:1721461
|
Bolton C |
The ability of myelin basic protein-sensitised leukocytes to adoptively transfer experimental allergic encephalomyelitis following coculture with FK 506, cyclosporine, or prednisolone. |
1991 |
Transplant. Proc. |
pmid:1721462
|
McManus BM et al. |
Impact of FK 506 on myocarditis in the enteroviral murine model. |
1991 |
Transplant. Proc. |
pmid:1721463
|
Nossal GJ |
Summary of the First International FK 506 Congress: perspectives and prospects. |
1991 |
Transplant. Proc. |
pmid:1721464
|
Starzl TE et al. |
Notes on FK 506. |
1991 |
Transplant. Proc. |
pmid:1714647
|
Haba T et al. |
Pathological and immunohistochemical examination in the rat treated with FK 506. |
1991 |
Transplant. Proc. |
pmid:1714649
|
Lautenschlager I et al. |
Efficiency of FK 506 and CyA to prevent acute cellular rejection of pig liver allografts. |
1991 |
Transplant. Proc. |
pmid:1714650
|
Epand RF and Epand RM |
The new potent immunosuppressant FK-506 reverses multidrug resistance in Chinese hamster ovary cells. |
1991 |
Anticancer Drug Des. |
pmid:1714737
|
Ryu S and Yasunami Y |
The necessity of differential immunosuppression for prevention of immune rejection by FK506 in rat islet allografts transplanted into the liver or beneath the kidney capsule. |
1991 |
Transplantation |
pmid:1718064
|
Kuroki H et al. |
Morphological and immunological analysis of rats with long-term-surviving limb allografts induced by a short course of FK 506 or cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1703697
|
Starzl TE et al. |
Hepatotrophic properties in dogs of human FKBP, the binding protein for FK506 and rapamycin. |
1991 |
Transplantation |
pmid:1718068
|
Morris RE et al. |
Use of rapamycin for the suppression of alloimmune reactions in vivo: schedule dependence, tolerance induction, synergy with cyclosporine and FK 506, and effect on host-versus-graft and graft-versus-host reactions. |
1991 |
Transplant. Proc. |
pmid:1703698
|
Lane WS et al. |
Complete amino acid sequence of the FK506 and rapamycin binding protein, FKBP, isolated from calf thymus. |
1991 |
J. Protein Chem. |
pmid:1718307
|
Goto S et al. |
Effect of FK 506 and cyclosporine on heart allograft survival in rats. |
1991 |
Transplant. Proc. |
pmid:1703700
|
James DG |
Which immunomodulator? |
1991 |
Br J Clin Pract |
pmid:1718384
|
Flavin T et al. |
Initial experience with FK 506 as an immunosuppressant for nonhuman primate recipients of cardiac allografts. |
1991 |
Transplant. Proc. |
pmid:1703701
|